Could cause temporary or reversible harm; serious harm is unlikely.
Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).
| Brand name | LIDOCAINE |
| Generic name | LIDOCAINE |
| Active ingredient(s) | LIDOCAINE |
| Distributed by / for | SUN PHARMA /TARO |
| NDC | 51672-3008-5 |
| Full product label | Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist By: Taro Pharmaceuticals U.S.A. Inc. Hawthorne NY 70532 NDC: 51672-3008-5 |
| Recalling firm | SUN PHARMA /TARO |
| Distribution | Nationwide in the USA |
| Quantity | 65,328 50g jars |
| Recall initiated | 2026-08-31 |
| Report date | 2026-09-23 |
| Recall completed | — |
| Recall number | D-0848-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Hawthorne NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗